{"raw_mentions": "Gooden et al. reported trans-2-arylcyclopropylamine analogues that inhibit LSD1 with Ki values in the range of 188-566 micromolar.\nUeda et al. ((2009) J. Am. Chem Soc. 131(48):17536-17537) reported cyclopropylamine analogs selective for LSD1 over MAO-A and MAO-B that were designed based on reported X-ray crystal structures of these enzymes with a phenylcyclopropylamine-FAD adduct and a FAD-N-propargyl lysine peptide; the reported IC50 values for phenylcyclopropylamine were about 32 micromolar for LSD1 whereas compounds 1 and 2 had values of 2.5 and 1.9 micromolar respectively."}
{"final_json": [{"molecule_name": "trans-2-arylcyclopropylamine analogues", "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": "188-566", "unit": "micromolar", "is_logarithmic": false}, {"molecule_name": "phenylcyclopropylamine", "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "32", "unit": "micromolar", "is_logarithmic": false}, {"molecule_name": "compound 1", "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "2.5", "unit": "micromolar", "is_logarithmic": false}, {"molecule_name": "compound 2", "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "1.9", "unit": "micromolar", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units as required."}
{"raw_mentions": "FIG. 1 summarizes structure-activity relationship evolution of increased potency towards LSD1 as compared to MAOA and/or MAOB from compounds that were not selective (e.g., tranylcypromine (TCPA)) to compounds that are selective inhibitors of LSD1 with IC50 values in the low nanomolar range.\nFIG. 2 summarizes structure-activity relationship evolution of increased potency towards LSD1 and MAOB as compared to MAOA from compounds that were not selective for LSD1 and MAOB (e.g., tranylcypromine (TCPA)). The dual LSD1/MAOB compounds have IC50 values for these two targets in the low nanomolar range.\nFIG. 3 shows the results of a western blot stained for H3K4 methylation with SH-SYSY cells grown in the presence of Compound Dual-1(at 100 \u03bcM) or parnate (\u201cPNT\u201d) (at 250 \u03bcM) for 1, 2, and 3 days, showing that this compound, Dual-1, increases H3K4 methylation in cells in a time dependent manner."}
{"final_json": [{"molecule_name": "tranylcypromine (TCPA)", "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "low nanomolar range", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "tranylcypromine (TCPA)", "protein_target_name": "LSD1 and MAOB", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "low nanomolar range", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Compound Dual-1", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "100", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "parnate (PNT)", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "250", "unit": "\u03bcM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Preferably, a LSD1 inhibitor is a compound that exhibits more than 50% inhibition of LSD1 activity in the LSD1 assay of example 1 at 50 mcM, more preferably one that exhibits more than 50% inhibition of LSD1 activity in the LSD1 assay of example 1 at 10 mcM, still more preferably one that exhibits more than 50% inhibition of LSD1 activity in the LSD1 assay of example 1 at 1 mcM, and even more preferably one that exhibits more than 50% inhibition of LSD1 activity in the LSD1 assay of example 1 at a concentration of 0.5 mcM or less.\n* As used herein, the term \u201cselective LSD1 inhibitor\u201d, \u201cLSD1 selective inhibitor\u201d or \u201cselective inhibitor of LSD1\u201d refers to an LSD1 inhibitor which preferably has an IC50 value for LSD1 that is at least two-fold lower than its IC50 values for MAO-A and MAO-B.\n* Even more preferably, a selective LSD1 inhibitor has an IC50 value for LSD1 which is at least five-fold lower than its IC50 values for MAO-A and MAO-B.\n* Even more preferably, a selective LSD 1 inhibitor has an IC50 value for LSD1 which is at least ten-fold lower than its IC50 values for MAO-A and MAO-B.\n* Even more preferably, a selective LSD1 inhibitor has an IC50 value for LSD1 which is at least 20-fold lower than its IC50 values for MAO-A and MAO-B.\n* Even more preferably, a selective LSD1 inhibitor has an IC50 value for LSD1 which is at least 50-fold lower than its IC50 values for MAO-A and MAO-B.\n* Even more preferably, a selective LSD1 inhibitor has an IC50 value for LSD1 which is at least 100-fold lower than its IC50 values for MAO-A and MAO-B.\n* As used herein, the term \u201cselective inhibitor of LSD1 and MAOB\u201d, \u201cdual LSD1/MAO-B inhibitor\u201d, \u201cLSDI/MAO-B inhibitor\u201d, \u201cdual LSD1/MAOB selective inhibitor\u201d, \u201cdual inhibitor selective for LSD1 and MAO-B\u201d or \u201cdual inhibitor of LSD1 and MAO-B\u201d are used interchangeably and refers to an LSD1 inhibitor which preferably has IC50 values for LSD1 and MAO-B which arc at least two-fold lower than its IC50 value for MAO-A.\n* More preferably, a dual LSD1/MAO-B selective inhibitor has IC50 values for LSD1 and MAO-B which are at least five-fold lower than its IC50 value for MAO-A.\n* Even more preferably, a dual LSD1/MAO-B selective inhibitor has IC50 values for LSD1 and MAO-B which are at least ten-fold lower than its IC50 value for MAO-A.\n* Even more preferably, a dual LSD1/MAO-B selective inhibitor has IC50 values for LSD1 and MAO-B which are at least 20-fold lower than its IC50 value for MAO-A."}
{"final_json": [{"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": ">50%", "unit": "%", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1 and MAO-B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1 and MAO-B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1 and MAO-B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1 and MAO-B", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe invention provides a pharmaceutical composition for treating Philadelphia chromosome positive myeloproliferation comprising a pharmaceutically acceptable carrier and a compound which is a selective inhibitor of LSD1. Preferably, LSD1 selective inhibitors (or selective LSDI inhibitors) have IC50 values for LSD1 which are at least 2-fold lower than the IC50 value for MAOA and/or MAOB.\nThe invention also provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound which is a dual inhibitor selective for LSD1 and MAOB. Preferably, dual LSD1/MAOB inhibitors have IC50 values for LSD1 and MAOB which are at least 2-fold lower than the IC50 value for MAO-A.\nEven more preferably, LSD1 selective inhibitors have IC50 values for LSD1 which are at least 5-fold lower than the IC50 value for MAOA and/or MAOB.\nYet even more preferably, LSD1 selective inhibitors have IC50 values for LSD1 which are at least 10-fold lower than the IC50 value for MAOA and/or MAOB.\nEven more preferably, dual LSD1/MAOB inhibitors have IC50 values for LSDI and MAOB which are at least 5-fold lower than the 1050 value for MAO-A.\nYet even more preferably, dual LSD1/MAOB inhibitors have IC50 values for LSD1 and MAOB which are at least 10-fold lower than the IC50 value for MAO-A."}
{"final_json": [{"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "2-fold lower", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "2-fold lower", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "5-fold lower", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "10-fold lower", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "5-fold lower", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "LSD1", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "IC50", "value": "10-fold lower", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nCompound 1&lt;0.20&gt;2&lt;0.20\nCompound 2&lt;0.20&gt;2&lt;0.20\nCompound 3&lt;0.10&gt;2&gt;2\nCompound 4&lt;0.10&gt;2&gt;2\nCompound 5&lt;0.20&gt;0.5&gt;1\nCompound 6&lt;0.07&gt;1&gt;1\nCompound 7&lt;0.07&gt;2&gt;2\nCompound 8&lt;0.07&gt;1&gt;10"}
{"final_json": [{"molecule_name": "Compound 1", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "<0.20", "unit": null, "is_logarithmic": false}, {"molecule_name": "Compound 2", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "<0.20", "unit": null, "is_logarithmic": false}, {"molecule_name": "Compound 3", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "<0.10", "unit": null, "is_logarithmic": false}, {"molecule_name": "Compound 4", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "<0.10", "unit": null, "is_logarithmic": false}, {"molecule_name": "Compound 5", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "<0.20", "unit": null, "is_logarithmic": false}, {"molecule_name": "Compound 6", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "<0.07", "unit": null, "is_logarithmic": false}, {"molecule_name": "Compound 7", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "<0.07", "unit": null, "is_logarithmic": false}, {"molecule_name": "Compound 8", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "<0.07", "unit": null, "is_logarithmic": false}]}
